Market Overview

Mike Khouw Sees Unusual Options Activity In Celgene

Related CELG
Benzinga's Daily Biotech Pulse: Acceleron On Fast Lane, OncoCyte's Accurate Diagnosis, Inspire Medical Gets Aetna Coverage
Jim Cramer Shares His Thoughts On Home Depot, Celgene And More
FDA committed to easing approval path for biosimilars (Seeking Alpha)

On CNBC's "Options Action", Mike Khouw spoke about unusually high options activity in Celgene Corporation (NASDAQ: CELG). The call options trading volume was three times the average daily call options volume on a day when the stock fell 4.44 percent.

Khouw noticed one big trade in the name. Around 1,500 contracts of the October 143 calls were traded for $1. The trade expires next Friday and it breaks even at $144 or 2.85 percent above the current market price. The options traders are betting that the stock can recover $4 of the $6.50 that it lost on Thursday.

Posted-In: CNBC Mike Khouw Options ActionOptions Markets Media


Related Articles (CELG)

View Comments and Join the Discussion!